CONTEST
Competed
$3,000
This contest is closed.
Problem
Patexia would like to disseminate the innovation of using sympathetic neural activity to indicate diseased conditions of the heart which contribute to sudden cardiac death. Neural activity, particularly monitored in the stellate ganglia, can indicate increased likelihood of cardiac arrhythmia and myocardial ischemia.
In particular, practitioners of this invention will monitor stellate ganglia neural activity, preferably with an implantable device (for example a nanoelectrode array). Upon detecting increases in sympathetic neural discharges according to this innovation practitioners will administer treatment for an impending myocardial ischemia or other diseased condition of the heart. To enter this contest, find a source demonstrating existing uses of this novel means of predicting increased likelihood of cardiac diseases associated with elevated sympathetic neural discharges after February 28th, 2005.
The following questions will help clarify the contest and eligible submissions. To be eligible for full prize amount, users should answer “yes” to at least questions 1-4. Additional questions will be used to determine a contest winner amongst multiple entries.
Questions
- Is the referenced use documented after February 28th, 2005?
- Does it describe sensing cardiac arrhythmia, myocardial ischemia or congestive heart failure, or another diseased condition of the heart?
- Does it describe monitoring sympathetic neural discharges?
- Does it involve detecting an increase in neural activity related to a diseased condition of the heart?
- Does it describe an implantable device used for this detection?
- Is the implanted device a nanoelectrode sensor array?
- Does the device produce an output signal upon detecting this increase in neural activity?
- Is the increased neural activity monitored from either of the stellate ganglia?
- Is the increase in neural activity determined by a twofold increase in amplitude or frequency of the sensed values?
- Is the increase in neural activity determined by comparing monitored neural activity to normal neural activity of the patient?
- Does the described use involve administering therapy in response to the output signal? For example, administering pharmacological agents, cardiac pacing, cardioversion or defibrillation.
Questions
| # | Question | Value |
|---|---|---|
| 1 | Is the referenced use documented after February 28th, 2005? | 0 |
| 2 | Does it describe sensing cardiac arrhythmia, myocardial ischemia or congestive heart failure, or another diseased condition of the heart? | 0 |
| 3 | Does it describe monitoring sympathetic neural discharges? | 0 |
| 4 | Does it involve detecting an increase in neural activity related to a diseased condition of the heart? | 0 |
| 5 | Does it describe an implantable device used for this detection? | 0 |
| 6 | Is the implanted device a nanoelectrode sensor array? | 0 |
| 7 | Does the device produce an output signal upon detecting this increase in neural activity? | 0 |
| 8 | Is the increased neural activity monitored from either of the stellate ganglia? | 0 |
| 9 | Is the increase in neural activity determined by a twofold increase in amplitude or frequency of the sensed values? | 0 |
| 10 | Is the increase in neural activity determined by comparing monitored neural activity to normal neural activity of the patient? | 0 |
| 11 | Does the described use involve administering therapy in response to the output signal? For example, administering pharmacological agents, cardiac pacing, cardioversion or defibrillation. | 0 |
Additional Notes
- This innovation is described in US patent 7,266,410 - “Method and System for the prediction of cardiac arrhythmias, myocardial ischemia, and other diseased condition of the heart associated with elevated sympathetic neural discharges,” and US patent 7,725,178 - “Method and system for the prediction of cardiac arrhythmias, myocardial ischemia, and other diseased conditions of the heart associated with elevated sympathetic neural discharges.”
- Submission deadline is Monday March 4th, 2013.
- All work must be prepared by a single researcher.
- Maximum of one entry per person allowed.
- Entries must be in English.
- If you were referred, the referral prize ($500) will be paid to the referring user from the total prize pool of $3000.
- Please make sure to answer all the questions and explain how we can find that in the reference.
- In case you are submitting foreign references, please provide a translation of key sections.
- If your reference has already been submitted by another researcher before you or is among the known references, it will not be considered for the contest.
- Please use “Ask a Question” to post general questions or feedback about the contest to the community.
- For specific questions, you can contact us directly by email at contests@patexia.com
- All submissions are subject to Patexia's contest legal terms. Failure to follow these rules may lead to disqualification from the contest
